Efficacy of levetiracetam: A review of three pivotal clinical trials

Epilepsia

Volumn 42, Issue SUPPL. 4, 2001, Pages 31-35

  Privitera, M ^a  

^a UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

Author keywords

Antiepileptic drugs; Clinical trials; Efficacy; Levetiracetam

Indexed keywords

ETIRACETAM; PLACEBO;

ADOLESCENT; ADULT; AGED; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; EPILEPSY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVIEW;

EID: 0034870692     PISSN: 00139580     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1528-1167.2001.00007.x     Document Type: Review

References (4)

1. Levetiracetam for partial seizures: Results of a double-blind, randomized clinical trial
2. Multicenter double-blind, randomized, placebo-controlled trial of levetiracetam as add-on therapy in patients with refractory partial seizures
3. Efficacy and tolerability of levetiracetam 3000 mg in patients with refractory partial seizures: A multicenter, double-blind, responder-selected study evaluating monotherapy